BALPHARMA.BOBALPHARMA.BOBSE
Loading
Operating Income PerformanceStrong
Percentile Rank87
3Y CAGR+1.9%
5Y CAGR+5.9%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+1.9%/yr
vs +10.9%/yr prior
5Y CAGR
+5.9%/yr
Recent deceleration
Acceleration
-9.0pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $187.74M | -5.1% |
| 2025 | $197.89M | -7.8% |
| 2024 | $214.57M | +21.1% |
| 2023 | $177.23M | +18.8% |
| 2022 | $149.18M | +6.1% |
| 2021 | $140.64M | +638.3% |
| 2020 | $-26.13M | -122.3% |
| 2019 | $117.05M | +10.5% |
| 2018 | $105.95M | +36.9% |
| 2017 | $77.40M | - |